Author

Lauren R Zeitels

Observed names: L. R. Zeitels, L. Zeitels, Lauren R. Zeitels, Lauren Zeitels, Lauren R. Zeitels

Institution: Massachusetts General Hospital

Observed institutions: Juvenile Diabetes Research Foundation, Johns Hopkins University, University of Cambridge, Johns Hopkins Medicine, National Institute for Health and Care Research, Massachusetts General Hospital, Breakthrough T1D UK, Addenbrooke's Hospital, NIHR Cambridge Biomedical Research Centre, The University of Texas Southwestern Medical Center, Wellcome Trust

OpenAlex ID: A5073259808

Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes

2007 · Genetics of Type 1 Diabetes in Finland, John A Todd, et al. · Nature Genetics · 1,457

Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation

2009 · Tsung-Cheng Chang, Lauren R. Zeitels, et al. · Proceedings of the National Academy of Sciences · 407

An Essential Mesenchymal Function for miR-143/145 in Intestinal Epithelial Regeneration

2014 · Raghu R. Chivukula, Guanglu Shi, et al. · Cell · 211

Association of the Vitamin D Metabolism Gene CYP27B1 With Type 1 Diabetes

2007 · Rebecca Bailey, Jason D. Cooper, et al. · Diabetes · 210

MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West Africa

2008 · T. Thye, S. Nejentsev, et al. · Human Molecular Genetics · 71

Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis

2014 · Lauren R. Zeitels, Asha Acharya, et al. · Genes & Development · 68

The candidate genes TAF5L, TCF7, PDCD1 , IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes

2007 · Jason D Cooper, Deborah J Smyth, et al. · BMC Medical Genetics · 58

Precise let-7 expression levels balance organ regeneration against tumor suppression

2015 · Linwei Wu, Liem H Nguyen, et al. · eLife · 56

HLA class II gene associations in African American Type 1 diabetes reveal a protective HLA‐DRB1*03 haplotype

2013 · J. M. M. Howson, M. S. Roy, et al. · Diabetic Medicine · 29

When 19 is greater than 92

2013 · Lauren R Zeitels, Joshua T Mendell · eLife · 3

Factors influencing patient preferences for oral versus intravenous (IV) enzyme replacement medication

2018 · Amel Karaa, Lauren Zeitels, et al. · Molecular Genetics and Metabolism

Author response: Precise let-7 expression levels balance organ regeneration against tumor suppression

2015 · Linwei Wu, Liem H Nguyen, et al.

Works count: 13

Citation count: 2,570

H-index: 9

I10-index: 9